SEQUENCEFOUR
Dead / Abandoned — Abandoned — no statement of use filed (as of 20 Oct 2025)
What this means for you
This application is over — abandoned 20 Oct 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97694840
- Mark type
- Stylized text
- Filed
- 28 Nov 2022
- Published for opposition
- 21 Jan 2025
- Abandoned
- 20 Oct 2025
- Attorney of record
- Jennifer Fraser
Goods and services
- Class 001 — Chemicals: Chemicals and biomolecules, namely, biological macromolecules, for industrial or scientific purposes other than for medical or veterinary purposes; Reagents for research purposes; Reagents for use in scientific apparatus for chemical or biological analysis and/or synthesis
- Class 005 — Pharmaceuticals: Chemical preparations for medical use, namely, biological macromolecules, namely, for therapeutic and preventive treatment of tumor diseases, infectious diseases, autoimmune disorders and allergies, for treatment of inherited genetic diseases or for protein or enzyme replacement therapy, and for treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, and for treatment of metabolic disorders; Pharmaceutical and veterinary preparations for medical and veterinary use; Pharmaceuticals and medicines based on biological macromolecules for the treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, for treatment or prevention of infectious diseases, allergies, autoimmune disorders and tumor diseases, for treatment of metabolic disorders and for treatment of inherited genetic diseases or for protein or enzyme replacement therapy; Gene therapeutic preparations; Dietetic substances adapted for medical use, in particular substances for food supplements; Vaccines
- Class 007 — Machines and machine tools: Machines for use in chemical or biopharmaceutical industry, namely for the synthesis of macromolecules; Bioreactors for the synthesis of macromolecules; Filling machines, in particular for use for filling biopharmaceutical compositions into containers; Industrial robots
- Class 009 — Scientific and electric apparatus: Laboratory apparatus and instruments, namely, pre-packed columns for use in chemical synthesis; mobile laboratory robots with artificial intelligence for use in scientific, diagnostic and pharmaceutical research and for use in pharmaceutical production and laboratory automation; mobile device for the synthesis of macromolecules, namely, for therapeutic and preventive treatment of tumor diseases, infectious diseases, autoimmune disorders and allergies, for treatment of inherited genetic diseases or for protein or enzyme replacement therapy, and for treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, and for treatment of metabolic disorders; Mobile production station of biological macromolecules, namely, for therapeutic and preventive treatment of tumor diseases, infectious diseases, autoimmune disorders and allergies, for treatment of inherited genetic diseases or for protein or enzyme replacement therapy, and for treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, and for treatment of metabolic disorders; bioreactors for growing cells
- Class 040 — Treatment of materials: Custom synthesis of chemical compounds, namely, biological macromolecules, to the order and specifications of others
- Class 042 — Scientific and technological services: Scientific and technological services and research, in particular for identification, testing and characterisation of biological molecules; pre-clinical and clinical testing of macromolecules
- Class 044 — Medical, beauty and agricultural services: Medical and veterinary services, in particular for therapeutic and preventive treatment of tumour diseases, infectious diseases, autoimmune disorders and allergies, for treatment of inherited genetic diseases or for protein or enzyme replacement therapy, and for treatment of neurological, neuromuscular, neurodegenerative and cardiovascular diseases, and for treatment of metabolic disorders; Vaccination
Owner
- CUREVAC MANUFACTURING GMBH, T?BINGEN, DE
- CUREVAC MANUFACTURING GMBH, T?BINGEN, DE
- CureVac RNA Printer GmbH, Tübingen, DE
Prosecution history
- 21 Oct 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 20 Oct 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 18 Mar 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 21 Jan 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 21 Jan 2025 — PUBLISHED FOR OPPOSITION
- 15 Jan 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 30 Dec 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 29 Dec 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 29 Dec 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 29 Dec 2024 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
- 04 Dec 2024 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 31 Oct 2024 — NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
- 31 Oct 2024 — INQUIRY TO SUSPENSION E-MAILED
- 31 Oct 2024 — SUSPENSION INQUIRY WRITTEN
- 29 Oct 2024 — SUSPENSION CHECKED - TO ATTORNEY FOR ACTION